Literature DB >> 16549919

Short contact therapy with tazarotene in psoriasis vulgaris.

Stefano Veraldi1, Ruggero Caputo, Alessia Pacifico, Ketty Peris, Rosario Soda, Sergio Chimenti.   

Abstract

BACKGROUND: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris.
OBJECTIVE: To evaluate whether irritant contact dermatitis caused by tazarotene was less frequent and/or less severe with SCT than with traditional therapy, and whether SCT with tazarotene was as effective as traditional therapy.
METHODS: Forty-three patients with plaque psoriasis were treated by SCT with 0.1% tazarotene gel (once daily application for 20 min, followed by washing with water). Treatment duration was 45 days.
RESULTS: Irritant contact dermatitis caused by tazarotene used as SCT was much less frequent and severe than traditional treatment with the same drug. SCT with tazarotene was effective in the treatment of plaque psoriasis.
CONCLUSION: Tazarotene, used as SCT, was better tolerated than the same drug used as traditional treatment. Furthermore, SCT appeared to be as effective as traditional therapy with the same drug. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549919     DOI: 10.1159/000091250

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

Review 1.  Use of tazarotene foam for the treatment of acne vulgaris.

Authors:  Stamatis Gregoriou; Eleftheria Kritsotaki; Alexandros Katoulis; Dimitris Rigopoulos
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-05-27

Review 2.  Topical Therapies in Psoriasis.

Authors:  R Torsekar; Manjyot M Gautam
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.